Exagen Inc. Common Stock XGN
HEALTHCARE · DIAGNOSTICS & RESEARCHi
Market dataready · fetched 2026-11-06T21:18:14.119Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T21:14:22.314603341Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-06T21:18:13.588764+00:00
Exagen Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | 5.11 | 317.5% | 29.9% | |||
| 35Δ | 5.46 | 303.0% | 26.7% | |||
| 40Δ | 5.81 | 288.6% | 23.5% | |||
| 45Δ | 12.28 | 559.5% | 131.5% | 6.17 | 274.1% | 20.3% |
| 50Δ | 6.52 | 259.6% | 17.1% | |||
| 55Δ | 6.97 | 351.9% | 40.7% | 6.87 | 245.2% | 13.9% |
| 60Δ | 6.37 | 337.6% | 33.0% | 7.22 | 230.7% | 10.8% |
| 65Δ | 5.77 | 323.3% | 25.2% | |||
| 70Δ | 5.17 | 309.0% | 17.5% | |||
| 75Δ | 4.53 | 382.3% | 14.9% | |||
| 80Δ | 3.88 | 491.6% | 14.5% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.11
- IV
- 317.5%
- B/E move
- 29.9%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.46
- IV
- 303.0%
- B/E move
- 26.7%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.81
- IV
- 288.6%
- B/E move
- 23.5%
45Δ
- Pseudo strike
- 12.28
- IV
- 559.5%
- B/E move
- 131.5%
- Pseudo strike
- 6.17
- IV
- 274.1%
- B/E move
- 20.3%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.52
- IV
- 259.6%
- B/E move
- 17.1%
55Δ
- Pseudo strike
- 6.97
- IV
- 351.9%
- B/E move
- 40.7%
- Pseudo strike
- 6.87
- IV
- 245.2%
- B/E move
- 13.9%
60Δ
- Pseudo strike
- 6.37
- IV
- 337.6%
- B/E move
- 33.0%
- Pseudo strike
- 7.22
- IV
- 230.7%
- B/E move
- 10.8%
65Δ
- Pseudo strike
- 5.77
- IV
- 323.3%
- B/E move
- 25.2%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 5.17
- IV
- 309.0%
- B/E move
- 17.5%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 4.53
- IV
- 382.3%
- B/E move
- 14.9%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 3.88
- IV
- 491.6%
- B/E move
- 14.5%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 118.44% | |
| 116.51% | |
| 115.25% | |
| 137.38% | |
| 127.26% | |
| 118.39% | |
| 111.26% | |
| 126.39% |
Diagnostics & Research
A
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global…
More →ADPT
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is…
More →BLLN
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company is headquartered in Menlo Park, California.
More →CDNA
Description unavailable
More →CRL
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell…
More →CSTL
Castle Biosciences Inc. is a pioneering diagnostics firm that enhances patient care through advanced gene-expression profiling tests, particularly within the skin cancer sector,…
More →